28
Oct

Advent Life Sciences is joining the parade of new biotech funds debuting this year. Based in London with an investment strategy that reaches into Europe and the U.S., Advent’s second dedicated life sciences fund has come up with $235 million to invest in about 15 early- to midstage companies in the next few years.

…read more

Source: Advent joins the parade of new biotech funds with $235M war chest

    

0 No comments